Digital tools for recording data can transform patient care from a series of episodic snapshots into a continuum, allowing health care providers to deliver the treatments needed faster. Naturally, these tools could be very valuable to pharmaceutical companies – both in pre-market research and post-market surveillance – and many of the biggest players in the sector have either been acquiring or collaborating with digital-only companies to augment their own product portfolios.
One such example of a collaboration between a big pharma company and a medtech is that of AstraZeneca PLC...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?